metricas
covid
Buscar en
Actas Urológicas Españolas (English Edition)
Toda la web
Inicio Actas Urológicas Españolas (English Edition) Association between testicular cancer and microlithiasis
Journal Information
Vol. 46. Issue 10.
Pages 587-599 (December 2022)
Share
Share
Download PDF
More article options
Visits
1
Vol. 46. Issue 10.
Pages 587-599 (December 2022)
Review article
Association between testicular cancer and microlithiasis
Cáncer de testículo asociado a microlitiasis testicular
Visits
1
M.D. Betancourt Sevillaa,
Corresponding author
mdbetancourts@uce.edu.ec

Corresponding author.
, D.F. Granda Gonzálezb
a Universidad Central del Ecuador, Quito, Ecuador
b Servicio Urología Oncológica, Hospital Sociedad de Lucha Contra el Cáncer SOLCA, Universidad Central del Ecuador, Quito, Ecuador
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (2)
Abstract
Introduction

Currently, no evidence determines the relationship between testicular microlithiasis by itself, or in relation with other factors, as a risk factor for the development of testicular tumors. There are no clear recommendations regarding the follow-up of this medical condition. Therefore, this review aims to provide a guide to monitoring these patients, supported by the literature.

Methodology

A literature review was carried out in December 2021 in PubMed, Cochrane, and Trip databases, and the selection of the articles was made following the PRISMA 2020 recommendations.

Results

Overall, the four systematic reviews chosen to conduct the final study determined that the combination of microlithiasis testicular with other risk factors further increased cancer development. However, the likelihood of testicular cancer risk is similar to that of the general population.

Conclusions

Patients at risk of developing testicular cancer should undergo personalized monitoring according to their age, associated risk factors, infertility, and testicular dysgenesis syndrome to determine their follow-up needs or perform a testicular biopsy.

Keywords:
Testicular diseases
Testicular neoplasms
Neoplasms
Germ cell and embryonal
Ultrasonics
Infertility
Resumen
Introducción

En la actualidad no existe evidencia que determine de forma concreta la relación entre microlitiasis testicular sola o en relación con otros factores como elemento de riesgo para el desarrollo de tumores testiculares, además de no existir recomendaciones claras sobre el seguimiento de esta condición. El objetivo de esta revisión es aportar con una guía para el seguimiento de estos pacientes basado en la evidencia de la literatura.

Métodos

Se realizó una revisión de literatura durante diciembre de 2021 en PubMed, base de datos Cochrane y Trip database, la selección de los artículos se realizó por medio las recomendaciones PRISMA 2020.

Resultados

Un total de 4 revisiones sistemáticas fueron seleccionadas para el trabajo final. Se logró determinar que la asociación de microlitiasis testicular a otros factores de riesgo incrementa aún más el riesgo de desarrollo de cáncer, sin embargo en ausencia de estos factores el riesgo el riesgo de cáncer testicular es similar al de la población general.

Conclusiones

En pacientes con riesgo de desarrollo de cáncer testicular se recomienda un seguimiento individualizado dependiendo de la edad, factores de riesgo asociados, infertilidad y síndrome de disgenesia testicular, para poder determinar la necesidad de seguimiento versus realización de biopsia testicular.

Palabras clave:
Testicular diseases
Testicular neoplasms
Neoplasms
Germ cell and embryonal
Ultrasonics
Infertility

Article

These are the options to access the full texts of the publication Actas Urológicas Españolas (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Actas Urológicas Españolas (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.acuroe.2023.12.002
No mostrar más